Crossmark

Real-World Safety of Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Systematic Review of Comparative Cohort Studies

Crossref DOI link: https://doi.org/10.1007/s11912-026-01774-7

Published Online: 2026-03-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koo, Juhee https://orcid.org/0009-0007-5241-2719
Yiu, Chin Hang https://orcid.org/0000-0001-7758-6087
Le, Hieu T. https://orcid.org/0000-0001-6812-7778
Winardi, Kevin https://orcid.org/0009-0007-7787-8208
Tan, Edwin C.K. https://orcid.org/0000-0003-2922-8837
Lu, Christine Y. https://orcid.org/0000-0002-7550-6837
Funding

Funding for this research was provided by:

The University of Sydney
License Information

Text and Data Mining valid from 2026-03-26

Version of Record valid from 2026-03-26
More Information

Article History

Received: 10 October 2025

Accepted: 10 March 2026

First Online: 26 March 2026

Declarations

:

: The authors declare no competing interests.